GWM
XRAY icon

Geneos Wealth Management’s Dentsply Sirona XRAY Stock Holding History

Geneos Wealth Management’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-455
Closed -$12.3K – 2971
2024
Q3 		$12.3K Buy
+455
New +$11.6K ﹤0.01% 1755
2022
Q4 		– Sell
-107
Closed -$3K – 2105
2022
Q3 		$3K Buy
+107
New +$3.66K ﹤0.01% 1814
2022
Q2 		– Sell
-15
Closed – – 2814
2022
Q1 		$0 Buy
+15
New +$793 ﹤0.01% 3013
2018
Q4 		– Sell
-230
Closed -$8K – 2494
2018
Q3 		$8K Hold
230
– – ﹤0.01% 1938
2018
Q2 		$10K Hold
230
– – ﹤0.01% 1740
2018
Q1 		$11K Hold
230
– – ﹤0.01% 1621
2017
Q4 		$15K Sell
230
-307
-57% -$19.5K ﹤0.01% 1500
2017
Q3 		$32K Buy
537
+263
+96% +$15.6K ﹤0.01% 1146
2017
Q2 		$17K Hold
274
– – ﹤0.01% 1347
2017
Q1 		$17K Hold
274
– – ﹤0.01% 1309
2016
Q4 		$15K Buy
274
+47
+21% +$2.78K ﹤0.01% 1313
2016
Q3 		$13K Buy
227
+33
+17% +$2.03K ﹤0.01% 1290
2016
Q2 		$12K Hold
194
– – ﹤0.01% 1283
2016
Q1 		$11K Buy
+194
New +$11.4K ﹤0.01% 1285

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geneos Wealth Management's XRAY Position: Q4 2024 in Review

Geneos Wealth Management sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 455 shares — an estimated $12.3K sold.

Geneos Wealth Management first reported a position in XRAY in Q1 2016 and held it in 14 quarters. The position peaked at $32K in Q3 2017. 361 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

  • Geneos Wealth Management reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 455 Dentsply Sirona shares in Q4 2024, an estimated $12.3K.
  • Geneos Wealth Management first reported a position in Dentsply Sirona in Q1 2016 and held it in 14 quarters.
  • Geneos Wealth Management's Dentsply Sirona position peaked at $32K in Q3 2017.
  • 361 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Geneos Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.